To investigate the expression of TGFβ1 and its receptor TGFβR2 and to examine whether their expression correlates with disease characteristics and clinical outcomes in adult patients with de novo AML, we collected 33 AML and 15 IDA bone marrow biopsy specimens. The gene discussed is TGFB1; the disease is acute myeloid leukemia.